ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 572,44
-0,79%
Dow Jones
40 211,72
0,00%
DAX
18 485,22
-0,62%
Brent Oil
82,865
-1,75%
Bitcoin
63 855,47
-1,54%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
06/10/201614h00Business WireTeva and Celltrion Announce Exclusive Biosimilar Commercial PartnershipNYSE:TEVATeva Pharmaceutical Industries Ltd
05/10/201619h10Dow Jones NewsTeva Sells Actavis Generics European Assets to Accord HealthcareNYSE:TEVATeva Pharmaceutical Industries Ltd
05/10/201617h17Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
05/10/201617h00Business WireTeva Announces Sale of UK and Ireland Actavis Assets and OperationsNYSE:TEVATeva Pharmaceutical Industries Ltd
03/10/201615h57Business WireTeva Completes Acquisition of Anda, Inc.NYSE:TEVATeva Pharmaceutical Industries Ltd
30/09/201612h07Edgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)NYSE:TEVATeva Pharmaceutical Industries Ltd
30/09/201610h00PR Newswire (US)EU Marketing Authorization Granted for Teva's Aerivio Spiromax® (fluticasone/salmeterol 500/50)NYSE:TEVATeva Pharmaceutical Industries Ltd
29/09/201621h52Business WireTeva Announces Launch of Generic Epzicom® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
28/09/201617h01Business WireKILL Teva Announces Launch of Generic Epzicom® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
22/09/201614h00Business WireTeva Announces Positive Top-Line Data from Second Phase III Study of SD-809 in Tardive Dyskinesia (TD)NYSE:TEVATeva Pharmaceutical Industries Ltd
20/09/201613h00Business WireTeva & Regeneron Announce Global Collaboration to Develop & Commercialize Fasinumab, an Investigational NGF Antibody for Chro...NYSE:TEVATeva Pharmaceutical Industries Ltd
20/09/201613h00PR Newswire (US)Regeneron and Teva Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for ...NYSE:TEVATeva Pharmaceutical Industries Ltd
19/09/201613h00Business WireTeva Announces Results from Exploratory 52-Week Phase 2 PRIDE-HD Study of Pridopidine in Huntington DiseaseNYSE:TEVATeva Pharmaceutical Industries Ltd
15/09/201615h00Business WireTeva Strengthens Injectables Portfolio with the Launch of an Authorized Generic of Cubicin® (Daptomycin for Injection) in th...NYSE:TEVATeva Pharmaceutical Industries Ltd
15/09/201614h00Business WireTeva to Develop Unique Wearable Tech & Machine Learning Platform for Continuous Measurement & Analysis of Huntington Disease ...NYSE:TEVATeva Pharmaceutical Industries Ltd
07/09/201614h00Business WireTeva to Present Latest Data in Multiple Sclerosis at 2016 ECTRIMS Congress in LondonNYSE:TEVATeva Pharmaceutical Industries Ltd
07/09/201601h01PR Newswire (US)Teva UK Study Reveals Generational 'Digital Divide' as UK Baby Boomers Fail to Embrace Benefits of 'Digital Healthcare'NYSE:TEVATeva Pharmaceutical Industries Ltd
06/09/201614h00Business WireTeva to Present at the Wells Fargo 2016 Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
30/08/201613h00Business WireTeva to Present New Respiratory Data at the 2016 European Respiratory Society (ERS) International CongressNYSE:TEVATeva Pharmaceutical Industries Ltd
29/08/201617h50Business WireTeva to Host Generic Medicines Business Overview on September 9, 2016NYSE:TEVATeva Pharmaceutical Industries Ltd
24/08/201623h46Business WireTeva Confirms PTAB’s Decisions on Two Patents in IPR Challenge to COPAXONE® 40 mgNYSE:TEVATeva Pharmaceutical Industries Ltd
18/08/201609h00Business WireEuropean Commission Grants Marketing Authorization for Teva’s CINQAERO® (reslizumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
10/08/201600h10Dow Jones NewsMylan Backs Year View After Sales Rise 8%NYSE:TEVATeva Pharmaceutical Industries Ltd
08/08/201623h13Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NYSE:TEVATeva Pharmaceutical Industries Ltd
08/08/201614h50Dow Jones NewsAllergan Revenue Increases, Though Loss WidensNYSE:TEVATeva Pharmaceutical Industries Ltd
05/08/201614h00Business WireTeva Announces Launch of Generic Gleevec® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
04/08/201620h47Dow Jones NewsTeva Profit Falls on Write-DownsNYSE:TEVATeva Pharmaceutical Industries Ltd
04/08/201613h00Business WireTeva Reports Second Quarter 2016 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
04/08/201609h03Dow Jones NewsBusiness Watch -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201615h21Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

USOTC
CNGLW
Canna Global Acquisition (PK)
NASDAQ
SNDL
Sundial Growers
LSE
SPED
Ivz Sp Eqw D
COIN
XRPUSD
Ripple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés